🇺🇸 NBIX — Neurocrine Biosciences, Inc.

Salud Compra fuerte
← Volver

Precio actual

164,63 USD

Máx. histórico

185,50

99 días

Caída desde máximo

-11,25%

Rango 52 semanas

122,14 – 186,12

Variación hoy

+3,05%

Cierre anterior

159,76

Rango de hoy

158,66 – 165,86

Volumen hoy

1.507.456

Peor caída histórica

-97,21%

15/03/2006 → 12/11/2009

Recuperado en 2911 días

Volatilidad anualizada ⓘ

61,30%

Información
Nombre completo
Neurocrine Biosciences, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Drug Manufacturers - Specialty & Generic
Empleados
2.500
PER ⓘ
24,43 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
207,50 USD (puede no estar actualizado)
Primera cotización
23/05/1996
Precio actualizado
hace 20 horas
Sobre la empresa

Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunological disorders in the United States and internationally. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; Orilissa tablets for endometriosis; Oriahnn capsules to treat uterine fibroids; and CRENESSITY to treat congenital adrenal hyperplasia, as well as offers products under the name of ALKINDI and Efmody. Its product candidates in clinical development includes NBI-1076986 to treat movement disorders; Osavampator for inadequate response to treatment in major depressive disorder; NBI-1117568 for the treatment of schizophrenia and bipolar mania; NBI-1117567 for the treatment of Alzheimer's disease; NBI 921355 for the treatment of epilepsy; NBIP-01435 for the treatment of congenital adrenal hyperplasia; NBIP-2118 for the treatment of obesity and related metabolic diseases; and NBI-1070770 to treat major depressive disorder; and NBI-1117570, NBI-1117567, NBI-1117569, NBI-1140675, and NBI-1065890 for neuropsychiatric and neurological conditions. The company also has license and collaboration agreements with Nxera Pharma UK Limited; Takeda Pharmaceutical Company Limited; Xenon Pharmaceuticals Inc.; Voyager Therapeutics, Inc.; Sanofi S.A.; Tanabe Pharma Corporation; and AbbVie Inc. The company was incorporated in 1992 and is headquartered in San Diego, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
03/03/2020 95,99 96,40 90,54 92,57 -3,88% 6,10% 920.200
02/03/2020 94,16 96,55 93,02 96,31 +1,70% 3,75% 775.000
28/02/2020 89,66 94,87 87,75 94,70 +2,99% 7,94% 1.100.100
27/02/2020 92,40 93,93 89,00 91,95 -2,13% 5,34% 1.349.200
26/02/2020 95,38 96,25 92,49 93,95 -0,36% 3,94% 903.800
25/02/2020 97,44 98,44 93,50 94,29 -2,72% 5,07% 719.600
24/02/2020 101,97 102,56 95,65 96,93 -6,91% 6,78% 1.073.500
21/02/2020 103,10 104,42 100,49 104,12 +0,94% 3,81% 630.700
20/02/2020 104,28 105,00 102,25 103,15 -1,01% 2,64% 571.900
19/02/2020 105,20 105,90 103,12 104,20 -0,53% 2,64% 444.600
18/02/2020 104,06 105,00 102,63 104,75 +0,43% 2,28% 425.100
14/02/2020 106,99 107,08 104,00 104,30 -2,02% 2,88% 454.300
13/02/2020 107,27 108,79 105,96 106,45 -1,09% 2,64% 459.100
12/02/2020 107,10 109,10 106,90 107,62 +0,61% 2,05% 517.000
11/02/2020 106,51 107,31 105,82 106,97 +0,92% 1,40% 388.900
10/02/2020 103,56 106,08 103,21 105,99 +1,93% 2,77% 496.800
07/02/2020 103,27 104,15 101,55 103,98 +1,05% 2,52% 520.800
06/02/2020 101,25 103,16 99,19 102,90 +0,42% 3,92% 813.600
05/02/2020 100,40 106,00 100,40 102,47 -0,61% 5,58% 1.513.800
04/02/2020 101,11 104,25 100,62 103,10 +2,64% 3,59% 1.091.100
03/02/2020 101,46 101,98 100,07 100,45 +0,37% 1,88% 667.300
31/01/2020 101,08 101,98 99,00 100,08 -1,41% 2,95% 731.900
30/01/2020 102,75 102,88 100,35 101,51 -1,67% 2,46% 403.100
29/01/2020 101,31 103,99 101,31 103,23 +1,61% 2,65% 783.400
28/01/2020 98,96 102,21 98,37 101,59 +2,98% 3,88% 842.800
27/01/2020 98,01 99,54 97,48 98,65 -0,52% 2,10% 605.300
24/01/2020 102,17 102,92 98,67 99,17 -2,95% 4,16% 678.800
23/01/2020 103,21 103,39 101,07 102,18 -1,25% 2,25% 696.700
22/01/2020 105,76 106,26 102,81 103,47 -2,04% 3,26% 580.400
21/01/2020 104,50 105,75 103,27 105,62 +0,91% 2,37% 954.600